Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCV13 Booster Immunogenicity Follow-on Study
NCT01095471Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Apr 2010
- Primary completion
- Dec 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Prevnar 13 in pneumococcal disease, sponsored by University of Oxford. Started Apr 2010; status: completed.
02
Drugs
Prevnar 13
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on NCT01095471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01095471.